Aung Myint, DO
Gastroenterology · Clearwater, FLNPI 1578907184
Payments from drug & device makers
Across 309 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Sanofi$490
- Gilead$314
- Madrigal Pharmaceuticals$301
- Pfizer$261
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,84497%
- Education$2243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 109 | $2,028 |
| Johnson & Johnson(2 entities) | 51 | $1,395 |
| Sanofi | 16 | $490 |
| Gilead | 17 | $314 |
| Madrigal Pharmaceuticals | 11 | $301 |
| Pfizer | 13 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $260 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $210 |
| Bristol Myers Squibb | 9 | $171 |
| Regeneron Healthcare Solutions, Inc. | 7 | $170 |
| Phathom Pharmaceuticals, Inc. | 2 | $134 |
| Medtronic | 2 | $128 |
| Merck | 7 | $125 |
| Braintree Laboratories, Inc. | 6 | $118 |
| Genentech, Inc. | 1 | $110 |
| Intercept Pharmaceuticals, Inc. | 5 | $109 |
| Mallinckrodt Hospital Products Inc. | 3 | $108 |
| Janssen Scientific Affairs, LLC | 1 | $97 |
| Boston Scientific | 3 | $91 |
| Novo Nordisk | 2 | $51 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Fujifilm Healthcare Americas Corporation | 1 | $45 |
| Ironwood Pharmaceuticals, Inc | 2 | $41 |
| Ardelyx, Inc. | 2 | $36 |
| Mauna Kea Technologies, Inc. | 1 | $25 |
| Stryker | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Sandoz | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EndoFlip$114
- Non-Covered Product$110
How this compares
$7,067 in reported general payments places this provider in the 65th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpclusaSofosbuvir/Velpatasvir | 12 | $285,657 |
| CreonLipase/Protease/Amylase | 57 | $169,211 |
| ZenpepLipase/Protease/Amylase | 64 | $125,694 |
| LinzessLinaclotide | 78 | $51,997 |
| TrulancePlecanatide | 16 | $16,931 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 545 | $9,534 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 40 | $6,894 |
| CholestyramineCholestyramine (With Sugar) | 79 | $5,871 |
| Pantoprazole Sodium | 547 | $5,612 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 15 | $2,428 |
| Sucralfate | 57 | $2,027 |
| Omeprazole | 166 | $1,615 |
| Dicyclomine Hcl | 36 | $1,609 |
| Lactulose | 40 | $1,588 |
| Budesonide DrBudesonide | 12 | $1,187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadEpclusa | $314 | $285,65712 claims |
| AbbVieCreon, Linzess | $2,028 | $221,208135 claims |
| Aimmune Therapeutics, Inc.Zenpep | $46 | $125,69464 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $210 | $16,93116 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $16 | $6,89440 claims |
| Braintree Laboratories, Inc.Sutab | $118 | $2,42815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Clearwater
- L Michael WeissClearwater$1.7M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.